Kathryn Walsh reports on a recent Cochrane systematic review of pharmacotherapies for cannabis dependence, which concludes that there is a lack of evidence for all medications reviewed.
[read the full story...]
Kathryn Walsh reports on a recent Cochrane systematic review of pharmacotherapies for cannabis dependence, which concludes that there is a lack of evidence for all medications reviewed.
[read the full story...]
Maartje Luijten, Assistant Professor at the Behavioural Science Institute at Radboud University, writes her debut blog on a recent meta-analysis of deficits in behavioural inhibition in substance abuse and addiction.
[read the full story...]
Kathryn Walsh summarises a systematic review which finds that cannabis use may exacerbate symptoms of mania in those with a diagnosis of bipolar disorder, and trigger symptoms of mania in the general population.
[read the full story...]
André Tomlin and Douglas Badenoch voice a note of caution about the Lancet Psychiatry meta-analysis of cannabis use in young people. The study links cannabis use in children with low educational attainment, cannabis dependence, illicit drug use and suicide attempts in later life.
[read the full story...]Matt Field summarises the findings of a recent cluster RCT that uses internet-based prevention (an Australian programme called Climate Schools) to reduce alcohol and cannabis use, truancy, psychological distress and moral disengagement.
[read the full story...]
This recent study concludes that childhood abuse creates an enduring vulnerability to psychosis that is realised in the event of exposure to further stressors and risk factors, such as separation, bereavement, or being involved in an accident or physical attack.
[read the full story...]
The National Institute for Health and Care Excellence (NICE) have recently searched for any new evidence that may be relevant to a public health guideline published in 2007; ‘Interventions to reduce substance misuse among vulnerable young people’. In this blog I summarise the new evidence that has emerged and highlight whether or not it is likely [read the full story…]
The relationship between cannabis and psychosis has been one of the hottest topics in psychiatry over the last decade, and with good reason. Policy-makers still disagree on whether cannabis should be legalised or how it should be classified, with Uruguay being the most recent country to legalise it. Drawing broadly from work initiated by Robin [read the full story…]
Cannabis is the second most commonly used recreational drug, after alcohol, in the UK. The number of regular users has risen considerably over the past decade, and this has been particularly apparent in the adolescent population. With this rise there have been concerns about the long term consequences of heavy cannabis use. Cannabis use has [read the full story…]
The NICE guideline on psychosis with coexisting substance misuse was published in 2011, which means it’s now nearly 3 years out of date. This is because guidelines take many months to produce, so by the time they are published the evidence in them is 1 year old at best. Some NICE guidelines are supplemented by [read the full story…]